Sarepta Therapeutics, Inc.
MX ˙ BMV ˙ US8036071004
SecurityMX:SRPT / Sarepta Therapeutics, Inc.
InstitutionGoldman Sachs Group Inc
Latest Disclosed Ownership1,078,252 shares
Latest Disclosed Value $ 23,462,753
Goldman Sachs Group Inc ownership in SRPT / Sarepta Therapeutics, Inc.

On May 15, 2026 - Goldman Sachs Group Inc filed a 13F-HR form disclosing ownership of 1,078,252 shares of Sarepta Therapeutics, Inc. (MX:SRPT) valued at $23,462,753 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 563,486 shares of Sarepta Therapeutics, Inc.. This represents a change in shares of 91.35% during the quarter.

Goldman Sachs Group Inc has a history of taking positions in derivatives of the underlying security (SRPT) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:SRPT / Sarepta Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F SAREPTA THERAPEUTICS CMN 803607100 1,078,252 514,766 91.35 23,463 93.49 0.0006
2026-02-10 2025-12-31 13F SAREPTA THERAPEUTICS CMN 803607100 563,486 386,335 218.08 12,126 255.29 0.0015
2025-11-14 2025-09-30 13F SAREPTA THERAPEUTICS CMN 803607100 177,151 -199,133 -52.92 3,414 -46.95 0.0004
2025-08-14 2025-06-30 13F SAREPTA THERAPEUTICS CMN 803607100 376,284 194,209 106.66 6,434 -44.63 0.0009
2025-06-27 2025-03-31 13F/A-2 SAREPTA THERAPEUTICS CMN 803607100 182,075 -294,991 -61.83 11,620 -79.97 0.0019
2025-05-16 2025-03-31 13F/A-1 SAREPTA THERAPEUTICS CMN 803607100 182,075 -294,991 11,620 0.0019
2025-05-09 2025-03-31 13F SAREPTA THERAPEUTICS CMN 803607100 296,275 -180,791 18,908 0.0006
2025-02-11 2024-12-31 13F SAREPTA THERAPEUTICS CMN 803607100 477,066 176,045 58.48 58,006 54.30 0.0091
2024-11-14 2024-09-30 13F SAREPTA THERAPEUTICS CMN 803607100 301,021 -138,556 -31.52 37,594 -45.87 0.0061
2024-08-13 2024-06-30 13F SAREPTA THERAPEUTICS CMN 803607100 439,577 189,530 75.80 69,453 114.55 0.0117
2024-05-15 2024-03-31 13F SAREPTA THERAPEUTICS CMN 803607100 250,047 65,177 35.26 32,371 81.58 0.0057
2024-05-14 2023-12-31 13F/A-2 SAREPTA THERAPEUTICS CMN 803607100 184,870 -558,022 -75.11 17,827 -80.20 0.0033
2024-03-01 2023-12-31 13F/A-1 SAREPTA THERAPEUTICS CMN 803607100 184,870 -558,022 17,827 0.0008
2024-02-13 2023-12-31 13F SAREPTA THERAPEUTICS CMN 803607100 184,870 -558,022 17,827 0.0032
2024-05-15 2023-09-30 13F/A-1 SAREPTA THERAPEUTICS CMN 803607100 742,892 -226,396 -23.36 90,053 -18.87 0.0192
2023-11-14 2023-09-30 13F SAREPTA THERAPEUTICS CMN 803607100 742,892 -226,396 90,053 0.0181
2024-05-14 2023-06-30 13F/A-1 SAREPTA THERAPEUTICS CMN 803607100 969,288 211,216 27.86 111,003 6.24 0.0238
2023-08-15 2023-06-30 13F SAREPTA THERAPEUTICS CMN 803607100 969,288 211,216 111,003 0.0224
2024-05-14 2023-03-31 13F/A-1 SAREPTA THERAPEUTICS CMN 803607100 758,072 -480,755 -38.81 104,485 -34.91 0.0240
2023-05-11 2023-03-31 13F SAREPTA THERAPEUTICS CMN 803607100 758,072 -480,755 104,485 0.0223
2024-05-14 2022-12-31 13F/A-1 SAREPTA THERAPEUTICS CMN 803607100 1,238,827 102,134 8.99 160,527 128,321.60 0.0394
2023-02-13 2022-12-31 13F SAREPTA THERAPEUTICS CMN 803607100 1,238,827 102,134 160,527 0.0359
2024-05-14 2022-09-30 13F/A-1 SAREPTA THERAPEUTICS CMN 803607100 1,136,693 -274,230 -19.44 126 19.05 0.0317
2022-11-14 2022-09-30 13F SAREPTA THERAPEUTICS CMN 803607100 1,136,693 -274,230 125,650 0.0290
2024-05-14 2022-06-30 13F/A-2 SAREPTA THERAPEUTICS CMN 803607100 1,410,923 486,867 52.69 106 -99.85 0.0264
2022-08-18 2022-06-30 13F/A-1 SAREPTA THERAPEUTICS CMN 803607100 1,410,923 486,867 105,763 0.0239
2022-08-15 2022-06-30 13F SAREPTA THERAPEUTICS CMN 803607100 1,410,923 486,867 105,763 0.0072
2022-05-16 2022-03-31 13F SAREPTA THERAPEUTICS CMN 803607100 924,056 -82,149 -8.16 72,188 -20.33 0.0152
2022-02-17 2021-12-31 13F/A-1 SAREPTA THERAPEUTICS CMN 803607100 1,006,205 133,210 15.26 90,609 12.23 0.0180
2022-02-14 2021-12-31 13F SAREPTA THERAPEUTICS CMN 803607100 1,006,205 133,210 90,609 0.0052
2022-01-20 2021-09-30 13F/A-1 SAREPTA THERAPEUTICS CMN 803607100 872,995 -17,004 -1.91 80,734 16.69 0.0171
2021-11-10 2021-09-30 13F SAREPTA THERAPEUTICS CMN 803607100 872,995 -17,004 80,734 0.0050
2021-08-13 2021-06-30 13F SAREPTA THERAPEUTICS CMN 803607100 889,999 175,587 24.58 69,189 29.94 0.0155
2021-05-17 2021-03-31 13F SAREPTA THERAPEUTICS CMN 803607100 714,412 -335,605 -31.96 53,245 -70.26 0.0134
2021-02-12 2020-12-31 13F SAREPTA THERAPEUTICS CMN 803607100 1,050,017 -204,564 -16.31 179,017 1.61 0.0461
2020-11-13 2020-09-30 13F SAREPTA THERAPEUTICS CMN 803607100 1,254,581 1,393 0.11 176,181 -12.32 0.0500
2020-08-12 2020-06-30 13F SAREPTA THERAPEUTICS CMN 803607100 1,253,188 -72,684 -5.48 200,937 54.93 0.0610
2020-05-15 2020-03-31 13F SAREPTA THERAPEUTICS CMN 803607100 1,325,872 217,352 19.61 129,697 -9.33 0.0457
2020-02-14 2019-12-31 13F SAREPTA THERAPEUTICS CMN 803607100 1,108,520 81,222 7.91 143,044 84.87 0.0364
2019-11-14 2019-09-30 13F SAREPTA THERAPEUTICS CMN 803607100 1,027,298 464,818 82.64 77,376 -9.47 0.0224
2019-08-14 2019-06-30 13F SAREPTA THERAPEUTICS CMN 803607100 562,480 -110,793 -16.46 85,469 6.51 0.0246
2019-05-15 2019-03-31 13F SAREPTA THERAPEUTICS CMN 803607100 673,273 41,069 6.50 80,247 16.31 0.0242
2019-02-14 2018-12-31 13F SAREPTA THERAPEUTICS CMN 803607100 632,204 94,960 17.68 68,992 -20.49 0.0220
2018-11-14 2018-09-30 13F SAREPTA THERAPEUTICS CMN 803607100 537,244 -298,470 -35.71 86,771 -21.45 0.0224
2018-08-14 2018-06-30 13F SAREPTA THERAPEUTICS CMN 803607100 835,714 152,785 22.37 110,465 118.32 0.0299
2018-05-15 2018-03-31 13F SAREPTA THERAPEUTICS CMN 803607100 682,929 -56,886 -7.69 50,598 22.92 0.0129
2018-02-14 2017-12-31 13F SAREPTA THERAPEUTICS CMN 803607100 739,815 74,852 11.26 41,163 36.47 0.0098
2017-11-14 2017-09-30 13F SAREPTA THERAPEUTICS CMN 803607100 664,963 -149,005 -18.31 30,163 9.93 0.0074
2017-08-14 2017-06-30 13F SAREPTA THERAPEUTICS CMN 803607100 813,968 281,076 52.75 27,439 73.96 0.0071
2017-05-18 2017-03-31 13F/A-1 SAREPTA THERAPEUTICS CMN 803607100 532,892 294,529 123.56 15,773 141.21 0.0043
2017-05-15 2017-03-31 13F SAREPTA THERAPEUTICS CMN 803607100 532,892 15,773
2017-02-14 2016-12-31 13F SAREPTA THERAPEUTICS CMN 803607100 238,363 -44,620 -15.77 6,539 -62.37 0.0018
2016-11-14 2016-09-30 13F SAREPTA THERAPEUTICS CMN 803607100 282,983 -158,793 -35.94 17,378 106.29 0.0053
2016-08-15 2016-06-30 13F SAREPTA THERAPEUTICS CMN 803607100 441,776 326,849 284.40 8,424 275.57 0.0028
2016-05-13 2016-03-31 13F SAREPTA THERAPEUTICS CMN 803607100 114,927 100,042 672.10 2,243 290.09 0.0007
2016-02-16 2015-12-31 13F SAREPTA THERAPEUTICS CMN 803607100 14,885 -11,314 -43.18 575 -31.63 0.0002
2015-11-13 2015-09-30 13F SAREPTA THERAPEUTICS CMN 803607100 26,199 -80,609 -75.47 841 -74.12 0.0003
2015-08-14 2015-06-30 13F SAREPTA THERAPEUTICS CMN 803607100 106,808 47,547 80.23 3,250 312.96 0.0010
2015-05-15 2015-03-31 13F SAREPTA THERAPEUTICS CMN 803607100 59,261 -27,720 -31.87 787 -37.49 0.0003
2015-02-13 2014-12-31 13F SAREPTA THERAPEUTICS CMN 803607100 86,981 63,757 274.53 1,259 156.94 0.0004
2014-11-14 2014-09-30 13F SAREPTA THERAPEUTICS CMN 803607100 23,224 -15,652 -40.26 490 -57.69 0.0002
2014-08-14 2014-06-30 13F SAREPTA THERAPEUTICS CMN 803607100 38,876 16,708 75.37 1,158 117.26 0.0004
2014-05-15 2014-03-31 13F SAREPTA THERAPEUTICS CMN 803607100 22,168 15,320 223.71 533 283.45 0.0002
2014-02-14 2013-12-31 13F SAREPTA THERAPEUTICS CMN 803607100 6,848 -2,087 -23.36 139 -67.06 0.0000
2013-11-14 2013-09-30 13F SAREPTA THERAPEUTICS CMN 803607100 8,935 -136,630 -93.86 422 -92.38 0.0002
2013-08-14 2013-06-30 13F SAREPTA THERAPEUTICS CMN 803607100 145,565 136,373 1,483.61 5,537 2,236.29 0.0021
2013-06-14 2012-12-31 13F/A-1 SAREPTA THERAPEUTICS CMN 803607100 9,192 -11,613 -55.82 237 -26.63 0.0001
2013-06-14 2012-09-30 13F/A-2 SAREPTA THERAPEUTICS CMN 803607100 20,805 20,805 323 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F SAREPTA THERAPEUTICS CMN Call 0 -100.00 0 -100.00 n/a n/a n/a
2026-02-10 2025-12-31 13F SAREPTA THERAPEUTICS CMN Call 57,100 -49.02 1,229 -43.10 n/a n/a n/a
2025-11-14 2025-09-30 13F SAREPTA THERAPEUTICS CMN Call 112,000 -48.48 2,158 -41.94 n/a n/a n/a
2025-08-14 2025-06-30 13F SAREPTA THERAPEUTICS CMN Call 217,400 280.74 3,718 2.00 n/a n/a n/a
2025-06-27 2025-03-31 13F/A SAREPTA THERAPEUTICS CMN Call 57,100 -1.04 3,644 -48.05 n/a n/a n/a
2025-05-16 2025-03-31 13F/A SAREPTA THERAPEUTICS CMN Call 57,100 3,644 n/a n/a n/a
2025-02-11 2024-12-31 13F SAREPTA THERAPEUTICS CMN Call 57,700 1.05 7,016 -1.63 n/a n/a n/a
2024-11-14 2024-09-30 13F SAREPTA THERAPEUTICS CMN Call 57,100 7,131 n/a n/a n/a
2024-05-14 2023-06-30 13F/A SAREPTA THERAPEUTICS CMN Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-08-15 2023-06-30 13F SAREPTA THERAPEUTICS CMN Call 0 0 n/a n/a n/a
2024-05-14 2023-03-31 13F/A SAREPTA THERAPEUTICS CMN Call 63,400 134.81 8,738 149.80 n/a n/a n/a
2023-05-11 2023-03-31 13F SAREPTA THERAPEUTICS CMN Call 63,400 8,738 n/a n/a n/a
2024-05-14 2022-12-31 13F/A SAREPTA THERAPEUTICS CMN Call 27,000 3,499 n/a n/a n/a
2023-02-13 2022-12-31 13F SAREPTA THERAPEUTICS CMN Call 27,000 3,499 n/a n/a n/a
2022-05-16 2022-03-31 13F SAREPTA THERAPEUTICS CMN Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-17 2021-12-31 13F/A SAREPTA THERAPEUTICS CMN Call 55,500 0.00 4,998 -2.63 n/a n/a n/a
2022-02-14 2021-12-31 13F SAREPTA THERAPEUTICS CMN Call 55,500 4,998 n/a n/a n/a
2022-01-20 2021-09-30 13F/A SAREPTA THERAPEUTICS CMN Call 55,500 0.00 5,133 18.96 n/a n/a n/a
2021-11-10 2021-09-30 13F SAREPTA THERAPEUTICS CMN Call 55,500 5,133 n/a n/a n/a
2021-08-13 2021-06-30 13F SAREPTA THERAPEUTICS CMN Call 55,500 -10.63 4,315 -6.76 n/a n/a n/a
2021-05-17 2021-03-31 13F SAREPTA THERAPEUTICS CMN Call 62,100 -64.99 4,628 -84.70 n/a n/a n/a
2021-02-12 2020-12-31 13F SAREPTA THERAPEUTICS CMN Call 177,400 111.95 30,245 157.32 n/a n/a n/a
2020-11-13 2020-09-30 13F SAREPTA THERAPEUTICS CMN Call 83,700 -22.71 11,754 -32.31 n/a n/a n/a
2020-08-12 2020-06-30 13F SAREPTA THERAPEUTICS CMN Call 108,300 -52.02 17,365 -21.35 n/a n/a n/a
2020-05-15 2020-03-31 13F SAREPTA THERAPEUTICS CMN Call 225,700 38.64 22,078 5.09 n/a n/a n/a
2020-02-14 2019-12-31 13F SAREPTA THERAPEUTICS CMN Call 162,800 69.06 21,008 189.65 n/a n/a n/a
2019-11-14 2019-09-30 13F SAREPTA THERAPEUTICS CMN Call 96,300 7.24 7,253 -46.84 n/a n/a n/a
2019-08-14 2019-06-30 13F SAREPTA THERAPEUTICS CMN Call 89,800 85.54 13,645 136.52 n/a n/a n/a
2019-05-15 2019-03-31 13F SAREPTA THERAPEUTICS CMN Call 48,400 384.00 5,769 428.78 n/a n/a n/a
2019-02-14 2018-12-31 13F SAREPTA THERAPEUTICS CMN Call 10,000 -73.47 1,091 -82.08 n/a n/a n/a
2018-11-14 2018-09-30 13F SAREPTA THERAPEUTICS CMN Call 37,700 277.00 6,089 360.59 n/a n/a n/a
2018-08-14 2018-06-30 13F SAREPTA THERAPEUTICS CMN Call 10,000 1,322 n/a n/a n/a
2018-05-15 2018-03-31 13F SAREPTA THERAPEUTICS CMN Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-02-14 2017-12-31 13F SAREPTA THERAPEUTICS CMN Call 40,000 -84.95 2,226 -81.53 n/a n/a n/a
2017-11-14 2017-09-30 13F SAREPTA THERAPEUTICS CMN Call 265,700 12,052 n/a n/a n/a
2017-05-18 2017-03-31 13F/A SAREPTA THERAPEUTICS CMN Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-02-14 2016-12-31 13F SAREPTA THERAPEUTICS CMN Call 113,000 -58.61 3,100 -81.51 n/a n/a n/a
2016-11-14 2016-09-30 13F SAREPTA THERAPEUTICS CMN Call 273,000 589.39 16,765 2,120.53 n/a n/a n/a
2016-08-15 2016-06-30 13F SAREPTA THERAPEUTICS CMN Call 39,600 42.45 755 39.04 n/a n/a n/a
2016-05-13 2016-03-31 13F SAREPTA THERAPEUTICS CMN Call 27,800 -82.79 543 -91.29 n/a n/a n/a
2016-02-16 2015-12-31 13F SAREPTA THERAPEUTICS CMN Call 161,500 32.92 6,231 59.73 n/a n/a n/a
2015-11-13 2015-09-30 13F SAREPTA THERAPEUTICS CMN Call 121,500 2,937.50 3,901 3,097.54 n/a n/a n/a
2015-08-14 2015-06-30 13F SAREPTA THERAPEUTICS CMN Call 4,000 -89.30 122 -75.45 n/a n/a n/a
2015-05-15 2015-03-31 13F SAREPTA THERAPEUTICS CMN Call 37,400 497 n/a n/a n/a
2015-02-13 2014-12-31 13F SAREPTA THERAPEUTICS CMN Call 0 -100.00 0 -100.00 n/a n/a n/a
2014-11-14 2014-09-30 13F SAREPTA THERAPEUTICS CMN Call 328,200 6,925 n/a n/a n/a
2014-08-14 2014-06-30 13F SAREPTA THERAPEUTICS CMN Call 0 -100.00 0 -100.00 n/a n/a n/a
2014-05-15 2014-03-31 13F SAREPTA THERAPEUTICS CMN Call 50,000 -81.20 1,202 -77.81 n/a n/a n/a
2014-02-14 2013-12-31 13F SAREPTA THERAPEUTICS CMN Call 265,900 55.41 5,416 -32.98 n/a n/a n/a
2013-11-14 2013-09-30 13F SAREPTA THERAPEUTICS CMN Call 171,100 8,081 n/a n/a n/a
2013-06-14 2012-12-31 13F/A SAREPTA THERAPEUTICS CMN Call 0 -100.00 0 -100.00 n/a n/a n/a
2013-06-14 2012-09-30 13F/A SAREPTA THERAPEUTICS CMN Call 50,000 777 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F SAREPTA THERAPEUTICS CMN Put 0 -100.00 0 -100.00 n/a n/a n/a
2026-02-10 2025-12-31 13F SAREPTA THERAPEUTICS CMN Put 57,100 0.00 1,229 11.64 n/a n/a n/a
2025-11-14 2025-09-30 13F SAREPTA THERAPEUTICS CMN Put 57,100 0.00 1,100 12.70 n/a n/a n/a
2025-08-14 2025-06-30 13F SAREPTA THERAPEUTICS CMN Put 57,100 0.00 976 -73.22 n/a n/a n/a
2025-06-27 2025-03-31 13F/A SAREPTA THERAPEUTICS CMN Put 57,100 -46.69 3,644 -72.02 n/a n/a n/a
2025-05-16 2025-03-31 13F/A SAREPTA THERAPEUTICS CMN Put 57,100 3,644 n/a n/a n/a
2025-02-11 2024-12-31 13F SAREPTA THERAPEUTICS CMN Put 107,100 25.85 13,022 22.53 n/a n/a n/a
2024-11-14 2024-09-30 13F SAREPTA THERAPEUTICS CMN Put 85,100 10,628 n/a n/a n/a
2024-05-14 2023-06-30 13F/A SAREPTA THERAPEUTICS CMN Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-08-15 2023-06-30 13F SAREPTA THERAPEUTICS CMN Put 0 0 n/a n/a n/a
2024-05-14 2023-03-31 13F/A SAREPTA THERAPEUTICS CMN Put 165,400 603.83 22,797 648.67 n/a n/a n/a
2023-05-11 2023-03-31 13F SAREPTA THERAPEUTICS CMN Put 165,400 22,797 n/a n/a n/a
2024-05-14 2022-12-31 13F/A SAREPTA THERAPEUTICS CMN Put 23,500 3,045 n/a n/a n/a
2023-02-13 2022-12-31 13F SAREPTA THERAPEUTICS CMN Put 23,500 3,045 n/a n/a n/a
2024-05-14 2022-09-30 13F/A SAREPTA THERAPEUTICS CMN Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-11-10 2022-09-30 13F SAREPTA THERAPEUTICS CMN Put 0 0 n/a n/a n/a
2022-08-18 2022-06-30 13F/A SAREPTA THERAPEUTICS CMN Put 40,800 3,058 n/a n/a n/a
2024-05-14 2022-06-30 13F/A SAREPTA THERAPEUTICS CMN Put 40,800 3 n/a n/a n/a
2022-08-15 2022-06-30 13F SAREPTA THERAPEUTICS CMN Put 40,800 3,058 n/a n/a n/a
2022-05-16 2022-03-31 13F SAREPTA THERAPEUTICS CMN Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-17 2021-12-31 13F/A SAREPTA THERAPEUTICS CMN Put 22,600 0.00 2,035 -2.63 n/a n/a n/a
2022-02-14 2021-12-31 13F SAREPTA THERAPEUTICS CMN Put 22,600 2,035 n/a n/a n/a
2022-01-20 2021-09-30 13F/A SAREPTA THERAPEUTICS CMN Put 22,600 0.00 2,090 18.95 n/a n/a n/a
2021-11-10 2021-09-30 13F SAREPTA THERAPEUTICS CMN Put 22,600 2,090 n/a n/a n/a
2021-08-13 2021-06-30 13F SAREPTA THERAPEUTICS CMN Put 22,600 -69.34 1,757 -68.01 n/a n/a n/a
2021-05-17 2021-03-31 13F SAREPTA THERAPEUTICS CMN Put 73,700 -80.04 5,493 -91.27 n/a n/a n/a
2021-02-12 2020-12-31 13F SAREPTA THERAPEUTICS CMN Put 369,200 9.98 62,945 33.52 n/a n/a n/a
2020-11-13 2020-09-30 13F SAREPTA THERAPEUTICS CMN Put 335,700 0.69 47,142 -11.81 n/a n/a n/a
2020-08-12 2020-06-30 13F SAREPTA THERAPEUTICS CMN Put 333,400 -29.72 53,457 15.19 n/a n/a n/a
2020-05-15 2020-03-31 13F SAREPTA THERAPEUTICS CMN Put 474,400 3.92 46,406 -21.22 n/a n/a n/a
2020-02-14 2019-12-31 13F SAREPTA THERAPEUTICS CMN Put 456,500 10.37 58,907 89.10 n/a n/a n/a
2019-11-14 2019-09-30 13F SAREPTA THERAPEUTICS CMN Put 413,600 34.33 31,152 -33.41 n/a n/a n/a
2019-08-14 2019-06-30 13F SAREPTA THERAPEUTICS CMN Put 307,900 6.58 46,785 35.87 n/a n/a n/a
2019-05-15 2019-03-31 13F SAREPTA THERAPEUTICS CMN Put 288,900 863.00 34,434 951.74 n/a n/a n/a
2019-02-14 2018-12-31 13F SAREPTA THERAPEUTICS CMN Put 30,000 -22.48 3,274 -47.62 n/a n/a n/a
2018-11-14 2018-09-30 13F SAREPTA THERAPEUTICS CMN Put 38,700 29.00 6,250 57.63 n/a n/a n/a
2018-08-14 2018-06-30 13F SAREPTA THERAPEUTICS CMN Put 30,000 3,965 n/a n/a n/a
2018-05-15 2018-03-31 13F SAREPTA THERAPEUTICS CMN Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-02-14 2017-12-31 13F SAREPTA THERAPEUTICS CMN Put 11,000 -96.85 612 -96.13 n/a n/a n/a
2017-11-14 2017-09-30 13F SAREPTA THERAPEUTICS CMN Put 349,000 1,736.84 15,831 2,373.59 n/a n/a n/a
2017-08-14 2017-06-30 13F SAREPTA THERAPEUTICS CMN Put 19,000 -81.73 640 -79.21 n/a n/a n/a
2017-05-18 2017-03-31 13F/A SAREPTA THERAPEUTICS CMN Put 104,000 105.13 3,078 121.28 n/a n/a n/a
2017-05-15 2017-03-31 13F SAREPTA THERAPEUTICS CMN Put 104,000 3,078 n/a n/a n/a
2017-02-14 2016-12-31 13F SAREPTA THERAPEUTICS CMN Put 50,700 -2.87 1,391 -56.61 n/a n/a n/a
2016-11-14 2016-09-30 13F SAREPTA THERAPEUTICS CMN Put 52,200 -86.43 3,206 -56.31 n/a n/a n/a
2016-08-15 2016-06-30 13F SAREPTA THERAPEUTICS CMN Put 384,800 83.24 7,338 79.02 n/a n/a n/a
2016-05-13 2016-03-31 13F SAREPTA THERAPEUTICS CMN Put 210,000 320.00 4,099 112.49 n/a n/a n/a
2016-02-16 2015-12-31 13F SAREPTA THERAPEUTICS CMN Put 50,000 1,929 n/a n/a n/a
2014-11-14 2014-09-30 13F SAREPTA THERAPEUTICS CMN Put 0 -100.00 0 -100.00 n/a n/a n/a
2014-08-14 2014-06-30 13F SAREPTA THERAPEUTICS CMN Put 15,300 -4.38 456 18.75 n/a n/a n/a
2014-05-15 2014-03-31 13F SAREPTA THERAPEUTICS CMN Put 16,000 384 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.